Discover how Melior’s unique phenotypic screening platforms can uncover the untapped value of your candidate therapeutic
Peritonitis can be triggered by a number of causes, such as infection, but invariably is associated with infiltration of an array of leukocytes into the peritoneal cavity. In turn, the trafficking of leukocytes is mediated by a number of cytokines. This is easily modelled in rodents.
Thioglycollate-mediated leukocyte recruitment and cytokine production in the peritoneum can be utilized as a model of inflammation, acute peritonitis and leukocyte/monocyte migration.
The inflammatory response generated in this model can be attenuated by administration of a number of known anti-inflammatory agents. In this study, we utilized Dexamethasone treatment to test for effects on thioglycollate-stimulated production of peritoneal monocyte chemoattractant protein-1 (MCP-1).
Ready to get started or looking for a custom model?
Contact us today for more information about our bespoke research models and to discuss how we can help you answer your unique research questions.
Dexamethasone was able to significantly reduce the levels of MCP-1 in the peritoneal cavity after thioglycollate administration. The reduction of MCP-1 levels is a reliable surrogate for the reduction in monocyte infiltration. This model stands as a good predictor of peritonitis therapeutic candidates. As a screen, it can point the way for further studies of promising compounds, by viewing relative levels of the cytokine MCP-1. Cell counts of different leukocytes and measurement of different cytokines can also be incorporated into this model.
This model is typically run in an acute setting, performed in a single day with a single administration of test article. As a model of peritonitis it is similar to the Zymosan A-induced Model of Peritonitis.